COST-EFFECTIVENESS ANALYSIS OF LIPID-MODIFYING THERAPY IN CANADA - COMPARISON OF HMG-COA REDUCTASE INHIBITORS IN THE PRIMARY PREVENTION OF CORONARY HEART-DISEASE
B. Jolain et D. Pettitt, COST-EFFECTIVENESS ANALYSIS OF LIPID-MODIFYING THERAPY IN CANADA - COMPARISON OF HMG-COA REDUCTASE INHIBITORS IN THE PRIMARY PREVENTION OF CORONARY HEART-DISEASE, Clinical therapeutics, 17(3), 1995, pp. 572-575